Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Premature Ovarian Failure: early-phase trial registry
A small indexed set (4 trials) with no open enrollment listed right now.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · none currently recruiting · #4,115 of 28,707 conditions by registered trial count
Premature Ovarian Failure: 4 US clinical trials tracked, none currently recruiting.
Premature Ovarian Failure is the subject of 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Illinois at Chicago, running 1 of these trials.
Enrollment posture brief
Registry condition premature-ovarian-failure
OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Premature Ovarian Failure has no open enrollment in this registry pull (4 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Premature Ovarian Failure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Premature Ovarian Failure is recruiting below its size-band peers.
0 of 4 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Ovarian Reserve After Cancer: Longitudinal Effects
University of Pennsylvania
NCT02467231
GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients
M.D. Anderson Cancer Center
NCT00429494
X-Chromosome Inactivation Status and Premature Ovarian Failure
University of Pittsburgh
NCT00295087
Rejuvenation of Premature Ovarian Failure With Stem Cells
University of Illinois at Chicago
NCT02696889
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Premature Ovarian Failure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Premature Ovarian Failure trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Premature Ovarian Failure page
4 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Premature Ovarian Failure trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- University of Illinois at Chicago sponsors the most Premature Ovarian Failure trials on record, review their full trial history before evaluating a specific study. See University of Illinois at Chicago's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Premature Ovarian Failure condition card totals 4 registered trials; most-linked intervention ROSE-1 Protocol; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.